These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 27154394)

  • 21. The "Performance of Rotavirus and Oral Polio Vaccines in Developing Countries" (PROVIDE) study: description of methods of an interventional study designed to explore complex biologic problems.
    Kirkpatrick BD; Colgate ER; Mychaleckyj JC; Haque R; Dickson DM; Carmolli MP; Nayak U; Taniuchi M; Naylor C; Qadri F; Ma JZ; Alam M; Walsh MC; Diehl SA; ; Petri WA
    Am J Trop Med Hyg; 2015 Apr; 92(4):744-51. PubMed ID: 25711607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of the intestinal microbiota on the immunogenicity of oral rotavirus vaccine given to infants in south India.
    Parker EPK; Praharaj I; Zekavati A; Lazarus RP; Giri S; Operario DJ; Liu J; Houpt E; Iturriza-Gómara M; Kampmann B; John J; Kang G; Grassly NC
    Vaccine; 2018 Jan; 36(2):264-272. PubMed ID: 29217369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous administration of rhesus rotavirus vaccine and oral poliovirus vaccine: immunogenicity and reactogenicity.
    Ho MS; Floyd RL; Glass RI; Pallansch MA; Jones B; Hamby B; Woods P; Penaranda ME; Kapikian AZ; Bohan G
    Pediatr Infect Dis J; 1989 Oct; 8(10):692-6. PubMed ID: 2554244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-polio enterovirus association with persistent diarrhea in children as revealed by a follow-up study of an Indian cohort during the first two years of life.
    Rao DC; Reddy H; Sudheendra K; Raghavendra A; Varadharaj V; Edula S; Goparaju R; Ratnakar B; Srinivasa Rao AS; Maiya PP; Ananda Babu M
    J Clin Virol; 2014 Sep; 61(1):125-31. PubMed ID: 24954472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concurrent oral poliovirus and rhesus-human reassortant rotavirus vaccination: effects on immune responses to both vaccines and on efficacy of rotavirus vaccines. The US Rotavirus Vaccine Efficacy Group.
    Rennels MB; Ward RL; Mack ME; Zito ET
    J Infect Dis; 1996 Feb; 173(2):306-13. PubMed ID: 8568290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interventions to improve oral vaccine performance: a systematic review and meta-analysis.
    Church JA; Parker EP; Kirkpatrick BD; Grassly NC; Prendergast AJ
    Lancet Infect Dis; 2019 Feb; 19(2):203-214. PubMed ID: 30712836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surveillance of immunity acquired from poliovirus immunization including vaccination with the Sabin strain-derived inactivated vaccine.
    Hotta C; Ogawa T; Shirasawa H
    Hum Vaccin Immunother; 2019; 15(5):1154-1159. PubMed ID: 30676843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rotavirus specific maternal antibodies and immune response to RV3-BB neonatal rotavirus vaccine in New Zealand.
    Chen MY; Kirkwood CD; Bines J; Cowley D; Pavlic D; Lee KJ; Orsini F; Watts E; Barnes G; Danchin M
    Hum Vaccin Immunother; 2017 May; 13(5):1126-1135. PubMed ID: 28059609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio Vaccine.
    Brickley EB; Strauch CB; Wieland-Alter WF; Connor RI; Lin S; Weiner JA; Ackerman ME; Arita M; Oberste MS; Weldon WC; Sáez-Llorens X; Bandyopadhyay AS; Wright PF
    J Infect Dis; 2018 Jan; 217(3):371-380. PubMed ID: 29304199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Head-to-head comparison of the immunogenicity of RotaTeq and Rotarix rotavirus vaccines and factors associated with seroresponse in infants in Bangladesh: a randomised, controlled, open-label, parallel, phase 4 trial.
    Velasquez-Portocarrero DE; Wang X; Cortese MM; Snider CJ; Anand A; Costantini VP; Yunus M; Aziz AB; Haque W; Parashar U; Sisay Z; Soeters HM; Hyde TB; Jiang B; Zaman K
    Lancet Infect Dis; 2022 Nov; 22(11):1606-1616. PubMed ID: 35961362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Host and viral factors affecting the decreased immunogenicity of Sabin type 3 vaccine after administration of trivalent oral polio vaccine to rural Mayan children.
    Maldonado YA; Peña-Cruz V; de la Luz Sanchez M; Logan L; Blandón S; Cantwell MF; Matsui SM; Millan-Velasco F; Valdespino JL; Sepulveda J
    J Infect Dis; 1997 Mar; 175(3):545-53. PubMed ID: 9041324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and immunogenicity of live attenuated quadrivalent human-bovine (UK) reassortant rotavirus vaccine administered with childhood vaccines to infants.
    Clements-Mann ML; Dudas R; Hoshino Y; Nehring P; Sperber E; Wagner M; Stephens I; Karron R; Deforest A; Kapikian AZ
    Vaccine; 2001 Sep; 19(32):4676-84. PubMed ID: 11535316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metagenomic sequencing of stool samples in Bangladeshi infants: virome association with poliovirus shedding after oral poliovirus vaccination.
    Tan SK; Granados AC; Bouquet J; Hoy-Schulz YE; Green L; Federman S; Stryke D; Haggerty TD; Ley C; Yeh MT; Jannat K; Maldonado YA; Andino R; Parsonnet J; Chiu CY
    Sci Rep; 2020 Sep; 10(1):15392. PubMed ID: 32958861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-polio enteroviruses and their association with acute diarrhea in children in India.
    Rao DC; Ananda Babu M; Raghavendra A; Dhananjaya D; Kumar S; Maiya PP
    Infect Genet Evol; 2013 Jul; 17():153-61. PubMed ID: 23602838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral polio vaccine response in the MAL-ED birth cohort study: Considerations for polio eradication strategies.
    Pan WK; Seidman JC; Ali A; Hoest C; Mason C; Mondal D; Knobler SL; Bessong P;
    Vaccine; 2019 Jan; 37(2):352-365. PubMed ID: 30442479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of increased inoculum on oral rotavirus vaccine take among infants in Dhaka, Bangladesh: A double-blind, parallel group, randomized, controlled trial.
    Lee B; Dickson DM; Alam M; Afreen S; Kader A; Afrin F; Ferdousi T; Damon CF; Gullickson SK; McNeal MM; Bak DM; Tolba M; Carmolli MP; Taniuchi M; Haque R; Kirkpatrick BD
    Vaccine; 2020 Jan; 38(1):90-99. PubMed ID: 31607603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of diarrheal disease on bivalent oral polio vaccine (bOPV) immune response in infants in Nepal.
    Cardemil CV; Estivariz C; Shrestha L; Sherchand JB; Sharma A; Gary HE; Oberste MS; Weldon WC; Bowen MD; Vinjé J; Schluter WW; Anand A; Mach O; Chu SY
    Vaccine; 2016 May; 34(22):2519-26. PubMed ID: 27085172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase I trial of RV3-BB rotavirus vaccine: a human neonatal rotavirus vaccine.
    Danchin M; Kirkwood CD; Lee KJ; Bishop RF; Watts E; Justice FA; Clifford V; Cowley D; Buttery JP; Bines JE
    Vaccine; 2013 May; 31(23):2610-6. PubMed ID: 23597719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of immune interference between inactivated polio vaccine and inactivated rotavirus vaccine co-administered by intramuscular injection in two animal species.
    Wang Y; Zade J; Moon SS; Weldon W; Pisal SS; Glass RI; Dhere RM; Jiang B
    Vaccine; 2019 Jan; 37(5):698-704. PubMed ID: 30626530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of Nonpolio Enteroviruses and the Bacterial Gut Microbiota on Oral Poliovirus Vaccine Response: A Study from South India.
    Praharaj I; Parker EPK; Giri S; Allen DJ; Silas S; Revathi R; Kaliappan SP; John J; Prasad JH; Kampmann B; Iturriza-Gómara M; Grassly NC; Kang G
    J Infect Dis; 2019 Apr; 219(8):1178-1186. PubMed ID: 30247561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.